Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-23

FDA Approved: TELMISARTAN — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

The FDA approved a supplemental application to authorize a generic telmisartan product from Chartwell RX, LLC. Telmisartan is used to treat hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)